Clinical Trials Directory

Trials / Completed

CompletedNCT02442505

Device-detected Paroxysmal Atrial Fibrillation

Validation of the Modified Microlife Blood Pressure Monitor in Patients With Paroxysmal Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
University of Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will use an automated blood pressure monitor (Microlife WatchBP03) with an inbuilt algorithm to detect atrial fibrillation (an irregular heart rhythm) in patients with an implanted pacemaker who have previously documented paroxysmal (intermittent) atrial fibrillation. This study will compare the Microlife device detected atrial fibrillation episodes to the pacemaker detected atrial fibrillation episodes.

Detailed description

The modified Microlife blood pressure monitor is able to detect atrial fibrillation (AF) with high sensitivity (95%) and specificity (86%) and has a positive predictive value of 68% and negative predictive value of 98% for single readings. In addition, the modified device was also able to accurately classify the majority of the anomalous non-AF rhythms, although the specificity was highly variable, dependent upon the rhythm. However sinus rhythm was detected with a specificity of 97%. However, we do not currently know if the device would demonstrate a similar sensitivity in detecting AF in patients with paroxysmal AF. Therefore, the present study will assess the sensitivity and specificity of the automated oscillometric device using a new AF algorithm among pacemaker patients with fast AF and atrial high-rate episodes and evaluate the effect of the specific rhythm abnormalities on the specificity for AF.

Conditions

Interventions

TypeNameDescription
DEVICEMicrolife WatchBP03 deviceMicrolife WatchBP03 device which is an automated oscillometric device using a new algorithm to detect atrial fibrillation

Timeline

Start date
2013-10-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-05-13
Last updated
2019-04-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02442505. Inclusion in this directory is not an endorsement.